Vigil Neuroscience, Inc. operates as a biotechnology company. The Company focuses on discovering and developing novel therapeutics in basic science and human genetics of microglia. Vigil Neuroscience serves customers in the United States.

Current Report (Form 8-K | Period ending 2025-08-04)

Quarterly Report (Form 10-Q | Period ending 2025-06-30)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Vigil Neuroscience (VIGL US)

Current Report (Form 8-K | Period ending 2025-08-04)

Quarterly Report (Form 10-Q | Period ending 2025-06-30)

Current Report (Form 8-K | Period ending 2025-07-28)

Current Report (Form 8-K | Period ending 2025-07-16)

DEFM14A | Definitive proxy statement relating to merger or acquisition

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)